Cite
MLA Citation
Aaron T. Gerds et al.. “Phase 1/2 trial of glasdegib in patients with primary or secondary myelofibrosis previously treated with ruxolitinib.” Leukemia research, vol. 79, 2019, pp. 38–44. http://access.bl.uk/ark:/81055/vdc_100078552252.0x00004b